Following patients with low platelets and a stroke
Part of Blood & lymphatic, Brain & nervous system, Heart & circulation, Immune system & allergy clinical trials.
This study follows patients who have both immune thrombocytopenia (ITP) and a recent ischemic stroke to learn more about their health over time. If you fit these criteria, joining may help doctors better understand how to care for people with these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with immune thrombocytopenia (ITP), a condition with low blood platelets.
- You have also had an acute ischemic stroke, a type of stroke from a blocked blood vessel in the brain.
- You received care at Peking University People's Hospital at some point since January 1, 2005.
- You do not have severe mental health issues that would make follow-up difficult.
- You are considered suitable for the study by the research team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have immune thrombocytopenia (ITP), a condition where the blood doesn't clot properly because of low platelets. By tracking patients over time, researchers hope to learn more about the disease and how it affects people.
This study looks at how people with immune thrombocytopenia (ITP) are treated in real life. It aims to understand which treatments work best for patients who have had ITP for up to 12 months.
This trial tests an IV medicine called V-IMMUNE® for people with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding. The study aims to see if V-IMMUNE® can safely raise platelet counts in both children and adults.
This trial looks at whether certain proteins in the blood can help doctors diagnose immune thrombocytopenia (ITP), a condition where your immune system destroys platelets. It may help find a faster, simpler way to confirm ITP.
This study collects data from people with immune thrombocytopenia (a condition where the immune system destroys platelets, causing low blood counts). It aims to better understand and track the disease over time.
This trial tests an intravenous immunoglobulin (IVIG) treatment for chronic immune thrombocytopenia (ITP), a condition where the immune system attacks platelets, causing low counts and bleeding risk. It aims to safely raise platelet levels using donated antibodies.
Hear when a new Immune Thrombocytopenia (ITP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.